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Abstract
INTRODUCTION: Despite evidence demonstrating the value of performance
initiatives, marked differences remain between hospitals in the delivery of care for
patients with sepsis. The aims of this study were to improve our understanding
of how compliance with the 3-h and 6-h Surviving Sepsis Campaign (SSC)
bundles are used in different geographic areas, and how this relates to outcome.
METHODS: This was a global, prospective, observational, quality improvement
study of compliance with the SSC bundles in patients with either severe sepsis or
septic shock. RESULTS: A total of 1794 patients from 62 countries were enrolled
in the study with either severe sepsis or septic shock. Overall compliance with all
the 3-h bundle metrics was 19%. This was associated with lower hospital mortality
than non-compliance (20 vs. 31%, p < 0.001). Overall compliance with all the 6-h
bundle metrics was 36%. This was associated with lower hospital mortality than
non-compliance (22 vs. 32%, p < 0.001). After ad...
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Abstract Introduction: Despite
evidence demonstrating the value of
performance initiatives, marked dif-
ferences remain between hospitals in
the delivery of care for patients with
sepsis. The aims of this study were to
improve our understanding of how
compliance with the 3-h and 6-h
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Surviving Sepsis Campaign (SSC)
bundles are used in different geo-
graphic areas, and how this relates to
outcome. Methods: This was a glo-
bal, prospective, observational,
quality improvement study of com-
pliance with the SSC bundles in
patients with either severe sepsis or
septic shock. Results: A total of
1794 patients from 62 countries were
enrolled in the study with either sev-
ere sepsis or septic shock. Overall
compliance with all the 3-h bundle
metrics was 19 %. This was associ-
ated with lower hospital mortality
than non-compliance (20 vs. 31 %,
p\ 0.001). Overall compliance with
all the 6-h bundle metrics was 36 %.
This was associated with lower hos-
pital mortality than non-compliance
(22 vs. 32 %, p\ 0.001). After
adjusting the crude mortality differ-
ences for ICU admission, sepsis status
(severe sepsis or septic shock), loca-
tion of diagnosis, APACHE II score
and country, compliance remained
independently associated with
improvements in hospital mortality
for both the 3-h bundle (OR = 0.64
(95 % CI 0.47-0.87), p = 0.004))
and 6-h bundle (OR = 0.71 (95 % CI
0.56-0.90), p = 0.005)). Discus-
sion: Compliance with all of the
evidence-based bundle metrics was
not high. Patients whose care inclu-
ded compliance with all of these
metrics had a 40 % reduction in the
odds of dying in hospital with the 3-h
bundle and 36 % for the 6-h bundle.
Keywords Sepsis 
Quality improvement 
Surviving Sepsis Campaign  Bundle
Introduction
Despite many advances in our understanding of sepsis [1]
and recent reports of improved outcomes from the con-
dition [2], the disorder remains of epidemic incidence
with an unacceptably high death rate and devastating
long-term effects. Quality improvement efforts through
the application of sepsis care bundles have reduced
mortality, but the number of hospitals participating in
such initiatives remains low [3, 4].
The Surviving Sepsis Campaign (SSC) was developed
to reduce the mortality from severe sepsis and septic
shock. SSC activities directed towards this goal included
the development of evidence-based guidelines [5–7],
educational packages to improve the awareness and
understanding of the condition and a quality improvement
initiative to help healthcare professionals adopt the
identified best practice [4, 8, 9]. A recent analysis cov-
ering a 7.5-year period demonstrated that active
participation in the SSC was associated with increased
guideline adherence, as evidenced by improved compli-
ance with established performance metrics. Additionally,
these improvements were in themselves associated with
reductions in sepsis-related mortality [4]. Finally, the
longer hospitals participated in the campaign and the
more they improved their performance, the greater were
the observed outcome improvements.
Despite evidence demonstrating the value of such
performance initiatives, marked differences remain
between hospitals in the delivery of care for patients
with sepsis. Reviewing the inconsistent application of
measures identifies an important opportunity to reduce
sepsis-induced mortality further. It is recognized that the
penetration of the SSC to hospitals around the world is
limited. To inform current and future quality improve-
ment efforts in sepsis, there is a need to better
understand how widely and well the evidence-based SSC
bundles are used in different geographic areas, and how
these relate to outcome. In particular, it is necessary to
assess the compliance with the 2012 guidelines and
associated bundles as all previous data assessed com-
pliance with the previous iterations. A critical step in
quality improvement efforts is a thorough assessment of
current practice in order to identify ongoing gaps in
clinical processes. This study was designed to address
this need.
Methods
Study design and participants
This was a global, prospective, observational, quality
improvement study of the prevalence of patients with
either severe sepsis or septic shock, with evidence-based
practices. On 7 November 2013 (0000 to 2400 hours),
consecutive patients presenting to either the emergency
department (ED) or being cared for in an ICU (either
intermediate care or intensive care) with severe sepsis or
septic shock were enrolled. To be eligible patients had to
have a high clinical suspicion of an infection, together
with a systemic inflammatory response and evidence of
acute organ dysfunction and/or shock [10]. Patients were
excluded if they were less than 18 years of age. Partici-
pating hospitals were identified through membership of
the European Society of Intensive Care Medicine
(ESICM), the Society of Critical Care Medicine (SCCM)
and the SSC and through the networks of national and
local coordinators. The project was approved as a quality
improvement initiative in each participating country, thus
precluding the necessity for written informed consent
from participants. All demographic and clinical infor-
mation were de-identified as part of data collection
processes so that patient anonymity was strictly main-
tained throughout the study.
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Procedures
Local investigators were identified and were supported by
a network of national coordinators. Key study information
was provided through a website (http://impress-ssc.com/)
which included the protocol, answers to key questions and
access to the electronic case report form (eCRF). Upon
entry into the eCRF, each patient was assigned a unique
study identifier. No patient identifiable data was submit-
ted to the online database housed on a secure server in
Germany.
A multi-continental panel of critical care experts
iteratively developed a ‘‘realistic data set’’. These data
elements included all key and relevant clinical and
demographic data points whilst not discouraging centres
from participating because of an excessive burden of data
collection (see Electronic supplementary material, ESM).
The data collected were all part of routine clinical care.
Patients were followed up until 30 days after study
enrolment or hospital discharge, whichever occurred first.
Data were collected for every patient, on whether their
management fulfilled the requirements of the SSC bun-
dles [7]. The 3-h bundle for patients with severe sepsis/
septic shock (i.e. elements completed within 3 h) includes
a lactate level measurement; blood cultures obtained prior
to the administration of antibiotics; the intravenous
administration of broad-spectrum antibiotics; and, intra-
venous administration of 30 mL/kg of crystalloid if
hypotension was present or the lactate level was at least
4 mmol/L (36 mg/dL). The 6-h bundle for patients with
severe sepsis/septic shock (i.e. elements completed within
6 h) includes a remeasurement of lactate if it was initially
raised; the application of vasopressors when hypotension
(mean arterial pressure [MAP] at most 65 mmHg) is
persistent despite initial fluid resuscitation; and, mea-
surement of central venous pressure (CVP) and central
venous oxygen saturation (ScvO2) when there is persistent
arterial hypotension despite volume resuscitation or the
initial lactate concentration is at least 4 mmol/L. The 6-h
bundle was reported for all patients in the study and also
just for those who remain with persistent hypotension
and/or hyperlactataemia following volume resuscitation
within the 6-h period.
Statistical analysis
Categorical variables are described using frequencies and
proportions and are compared using Fisher’s exact test.
Comparisons between geographic regions have been
made excluding the data from Oceania, owing to the low
numbers of patients enrolled from this region making the
estimates less reliable. Continuous variables are described
as mean and standard deviation if normally distributed or
median and interquartile range if not. A generalized
estimating equation (GEE) population-averaged logistic
regression was used to assess the association between
prognostic factors and mortality where country was the
clustering or panel variable with an exchangeable corre-
lation structure. Both unadjusted and adjusted odds ratios
are presented along with their associated 95 % confidence
intervals. The following adjustment variables of age, ICU
admission (yes vs. no), sepsis status (severe vs. shock),
location (ED, ward, ICU, OR, unknown), sepsis origin
(community, health care, hospital, or ICU acquired), and
APACHE II were determined a priori. All analyses were
run using Stata 13.1, StataCorp, College Station, TX.
Results
We collected data describing patients presenting with
severe sepsis and/or septic shock in 618 hospitals from 62
countries. Data were returned on 1927 patient records of
which 133 were removed having been identified as
duplicates or having missing hospital outcome data,
leaving 1794 for analysis (ESM Fig. 1). A median num-
ber of 9 (3-25) patients were included per country and 2
(1-4) per site. The two biggest participating regions were
Western Europe (623 (34.7 %)) and North America (501
(27.9 %)). The highest enrolling countries were the USA
(489 (27.3 %)), UK (199 (11.1 %)), Malaysia (144
(8.0 %)), Spain (141 (7.9 %)) and India (70 (3.9 %))
(ESM Table 1). Oceania had only 14 observations; thus,
their results have very wide confidence intervals.
Table 1 and ESM Tables 2 and 3 show the baseline
data and outcomes. Overall, 47 % of the patients were
over 65 years old and 59 % presented with at least one
co-morbid illness (ESM Tables 1 and 2). The majority of
patients were diagnosed in the ED (54 %) and the most
frequent presentations were of community-acquired sep-
sis (59.9 %) and pneumonia (40 %). The most common
organ dysfunctions at presentation were hypotension
(66 %), acute respiratory distress syndrome [11] (57 %)
and acute kidney injury (46 %). In 39 % of the patients
the sepsis progressed to septic shock (ESM Table 2). A
total of 1545 (86 %) of the patients were admitted to an
ICU and the overall hospital mortality was 28 % with a
median (IQR) length of hospital stay of 13.7 (6.5–24.6)
days.
Demographic and clinical details of patients present-
ing by region are described in Table 1. Patients were
more likely to be older in Western Europe and present
with chronic illnesses in North America. The diagnosis of
severe sepsis/septic shock was most likely to be made in
the ED in North America (64 %), the ward in Asia (24 %)
and the ICU in Eastern Europe (44 %). Unadjusted hos-
pital mortality was highest in Eastern Europe (44 %) and
lowest in Oceania (14 %). When the crude mortality rates
for each region were compared against North America
and adjusted for ICU admission, sepsis status, location of
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diagnosis, origin of sepsis, APACHE II score and coun-
try, East Europe and Central/South America remained
with higher odds of dying (OR = 2.46 (95 % CI
1.27-4.77), p = 0.008 and OR = 2.17 (95 % CI
1.16-4.03), p = 0.015), respectively) (Fig. 1). There
were no statistical differences found in adjusted mortality
rates between North America and Asia, Oceania, West
Europe and Africa/Middle East.
Overall compliance with all the 3-h bundle metrics
was 19 %. This was associated with lower hospital mor-
tality than non-compliance (20 vs. 31 %, p\ 0.001).
Overall compliance with all the 6-h bundle metrics was
36 %. This was associated with lower hospital mortality
than non-compliance (22 vs. 32 %, p\ 0.001) (Table 2).
For patients who had persistent hypotension and/or
hyperlactataemia full compliance with the 6-h bundle was
reported in 90 (11 %) of patients. The compliance with
the 3-h bundle was highest in North America (29 %) and
lowest in Central/South America (9.5 %), whereas the
compliance with the 6-h bundle was highest in West
Europe (41 %) and lowest in Africa/Middle East (26 %)
(Table 3). After adjusting the crude mortality differences
for ICU admission, sepsis status (severe sepsis or septic
shock), location of diagnosis, APACHE II score and
country, compliance remained independently associated
with improvements in hospital mortality for both the 3-h
bundle (OR = 0.64 (95 % CI 0.47-0.87), p = 0.004))
and 6-h bundle (OR = 0.71 (95 % CI 0.56-0.90),
p = 0.005)) (Table 4).
Discussion
In this multinational study of severe sepsis and septic
shock the hospital mortality rate was 28.4 % and this
varied significantly between different geographic regions
of the world. Compliance with all of the evidence-based
bundle metrics for the treatment of this condition was not
high: 19 % for the 3-h bundle and 35.5 % for the 6-h
bundle. Patients whose care included compliance with all
of these metrics had a 40 % reduction in the odds of dying
in hospital with the 3-h bundle and 36 % for the 6-h
bundle.
Despite recent reports of reducing mortality rates from
septic shock [2, 12] and data from recent randomized
controlled trials suggesting the mortality is now quite low
[13, 14], we found a hospital mortality rate of 28.4 %.
This is consistent with reports from other observational
studies [4, 15] that suggest the mortality rate may still be
higher than reported from interventional studies [16] that
often exclude the highest risk groups of patients, and also
more formally structure the delivery of care. We have also
found large differences in mortality between different
geographic regions. We have previously reported similar
findings when comparing Europe to North America where
the crude mortality rate was lower in North America, but
Fig. 1 Estimated mortality and its associated 95 % CI by region
where the number represents the observations within each region
Table 2 Surviving Sepsis Campaign bundle compliance and
associated hospital mortality for patients enrolled into the IMPreSS
study
Detail
3-h bundle compliance (all patients, n = 1794)
Measurement of lactate 1002 (55.9)
Obtain blood cultures before administration of
antibiotics
883 (49.2)
Administer broad-spectrum intravenous
antibiotics
1155 (64.4)
Administer 30 mL/kg crystalloid for hypotension 1017 (56.7)
Full bundle 340 (19.0)
Hospital mortality for 3-h bundle compliance 67/340 (19.7)
Hospital mortality for 3-h bundle non-
compliance
443/1454
(30.5)*
6-h bundle compliance (all patients, n = 1794)
Repeat the lactate measurement 1077 (60.0)
Application of vasopressors for hypotension 1479 (82.4)
Measurement of central venous pressure 1209 (67.4)
Measurement of central venous oxygen
saturation
1070 (59.6)
Full bundle 637 (35.5)
Hospital mortality for 6-h bundle compliance 143/637 (22.4)
Hospital mortality for 6-h bundle non-
compliance
367/1157
(31.7)*
6-h bundle compliance (for only patients with persistent
hypotension (MAP\65 mmHg) and/or hyperlactataemia
([4 mmol/L) after volume administration (n = 824)
Repeat the lactate measurement 530 (64.3)
Application of vasopressors for hypotension 544 (66.0)
Measurement of central venous pressure 274 (33.2)
Measurement of central venous oxygen
saturation
135 (16.4)
Full bundle 90 (10.9)
Hospital mortality for 6-h bundle compliance 25/90 (27.8)
Hospital mortality for 6-h bundle non-
compliance
261/734 (35.6)
All numbers are presented as n (%) unless otherwise stated
* Represents a p value of B0.0001 by the Fishers exact test for the
mortality of bundle compliance versus non-compliance
1624
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the difference did not remain after adjusting for baseline
confounding influences [17]. In this current study, the
differences between West Europe and North America
were not significant after adjustments; however, we have
been able to document significant differences between
North America and Central/South America and Eastern
Europe. Other authors have described differences in the
provision of intensive care facilitates and treatments
between and within continents [18–22], but this study
adds to this by extending the findings to a global scale.
The strengths of this study include the defined data set,
a web-based data entry portal, a website containing all
relevant documents and training manuals and the partic-
ipation from over 60 countries representing all parts of the
globe. We describe a cohort of patients with severe sepsis
and septic shock that could be identified in EDs and ICUs
in each participating country. We have previously pub-
lished [7] and extensively marketed [23–25] the evidence-
based bundle metrics so they were familiar to all partic-
ipating sites. We were then able to collect data describing
compliance with these metrics and also data describing
presentation patterns and severity of these patients,
enabling us to correct bundle compliance and outcome
metrics for such differences.
Our study has some limitations. Our data set was a
compromise between being an exhaustive list describing
all facets of a patient with sepsis and being small enough
to encourage site participation and data reliability. We
enrolled relatively few patients per site on a single study
day and for many countries only a few sites participated.
This reduces the external generalizability of our data set.
This ‘point’ estimate reduces the external validity as there
is likely to be significant variance in both admission
numbers of patients presenting to hospital and clinical
practice on a day to day basis and also does not
compensate for the known seasonal variations in inci-
dence of the condition in the different regions of the
world. In addition we only followed our patients up until
hospital discharge; therefore, we have little understanding
into what happened to the patients following discharge
and to where the patients went. This is likely to be very
different between countries in the study.
We have limited data describing other quality metrics
of the participating institutions. It is possible that the
association we have found between bundle compliance
and outcome improvement may be nothing more than a
surrogate of how well that institution performs. It would
be unwise to infer causality from this relationship. Indeed
results from several recent large randomized controlled
trials [13, 14, 26] have questioned the need for some of
the elements that are included in the 6-h bundle. These
new data are currently being assimilated into an update of
the evidence-based guidelines and the quality improve-
ment metrics will also change to reflect the new data, in
particular the emphasis placed on measurement of central
venous oxygen saturations as part of the overall proto-
colized resuscitation strategy.
Our study has confirmed the reports of others that
compliance with sepsis improvement metrics are not
good, although when performed they are associated with
outcome improvements. This study is the first report of
compliance with the 2012 SSC bundles [7] and as such
adds to the literature supporting this methodology for
quality improvement [4, 17, 27–29]. Our study confirms
previous reports that the rate of bundle compliance is
different between regions [4, 17] and confirms the ability
of sites in North America to perform the initial (3-h)
resuscitation bundle elements better that other regions,
but also suggests that Western Europe has higher com-
pliance with the 6-h elements. In addition we have
Table 4 Hospital mortality odds ratios based on general estimating equation (GEE) population-averaged logistic regression models
Detail Unadjusted hospital
mortality odds ratio
95 % CI p value Adjusted hospital
mortality odds ratio
95 % CI p value
Model 1. Hospital mortality by geographic regiona
North America (reference) 1.00 1.00
Asia 1.29 0.80-2.06 0.29 1.22 0.69-2.14 0.49
Oceania 0.52 0.11-2.51 0.41 0.28 0.03-2.67 0.27
West Europe 1.10 0.71-1.70 0.69 0.98 0.58-1.66 0.94
East Europe 2.47 1.41-4.31 0.001 2.46 1.27-4.77 0.008
Central/South America 1.77 1.05-3.00 0.033 2.17 1.16-4.03 0.015
Africa/Middle east 1.69 0.88-3.22 0.11 1.33 0.61-2/86 0.47
Model 2. Hospital mortality by Surviving Sepsis Campaign bundle complianceb
Full 3-h bundle 0.60 0.45-0.80 \0.001 0.64 0.47-0.87 0.004
Full 6-h bundle 0.64 0.52-0.80 \0.001 0.71 0.56-0.90 0.005
a Odds ratios are relative to North America and are adjusted for
age, ICU admission (yes vs. no), sepsis status (severe vs. shock),
location (ED, ward, ICU, OR, unknown), sepsis origin (community,
health care, hospital, or ICU acquired), and APACHE II and
country as the panel variable
b Odds ratios are relative to non-compliance with either the full 3-h
or 6-h bundle and are adjusted for ICU admission, sepsis status
(severe vs. shock), location (ED, ward, ICU, OR, unknown), and
APACHE II. Odds ratios are comparing compliance with non-
compliance and country as the panel variable
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confirmed the reports that compliance with these tools
improves outcome even when taking into account all
presenting differences [4, 17, 23, 25, 27, 28].
In conclusion we have observed in a large multina-
tional observational study that compliance with evidence-
based bundle metrics designed to improve outcomes from
septic shock remains low, varies significantly between
different geographical regions and when performed is
associated with improvements in outcome.
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